NATIVEL COLLINS: Open Payments
NPI 1437162690 · MANTACHIE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$935 in 51 payments from 11 companies in 2025. Trend: 2023 $4,263 · 2024 $866 · 2025 $935
Food & beverage: $903Education: $32
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $197 |
| Medtronic, Inc. | 1 | $139 |
| Lilly USA, LLC | 12 | $137 |
| Sequel Med Tech, LLC | 7 | $135 |
| Corcept Therapeutics | 5 | $97 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $62 |
| Esperion Therapeutics, Inc. | 1 | $25 |
| Insulet Corporation | 1 | $24 |
| CeQur Corporation | 1 | $21 |
Products named: MINIMED 780G, TWIIST, JARDIANCE, Korlym, MOUNJARO, FARXIGA, Ozempic, Rybelsus.
Industry payments across MS — which companies pay providers there.
